Article Dans Une Revue Structural Heart Année : 2020

A Longitudinal Echocardiographic Analysis of Patients Treated Using the Repositionable and Fully Retrievable Lotus Valve: A Sub-Analysis of the RESPOND Study

Osama Soliman
  • Fonction : Auteur
Chun-Chin Chang
  • Fonction : Auteur
Jochen Wohrle
  • Fonction : Auteur
David Hildick-Smith
  • Fonction : Auteur
Sabine Bleiziffer
  • Fonction : Auteur
Daniel J. Blackman
  • Fonction : Auteur
Mohamed Abdel-Wahab
  • Fonction : Auteur
Andrey Nersesov
  • Fonction : Auteur
Dominic J. Allocco
  • Fonction : Auteur
Ian T. Meredith
  • Fonction : Auteur
Volkmar Falk
  • Fonction : Auteur
Nicolas M. van Mieghem
  • Fonction : Auteur

Résumé

Background The Lotus aortic valve system is a transcatheter heart valve (THV) designed with a seal to minimize paravalvular leak (PVL). We evaluated hemodynamic performance, PVL and ventricular function up to 1-year after transcatheter aortic valve replacement (TAVR) using the Lotus THV in patients with severe aortic stenosis. Methods RESPOND was a prospective, single-arm, multicenter registry evaluating outcomes after Lotus TAVR in routine clinical practice. Core Laboratory adjudicated echocardiograms at baseline, discharge and 1-year were analyzed in a subgroup (N = 550) of patients with paired transthoracic echocardiography (TTE) at the 3 time points. Results Mean effective aortic valve orifice area (EOA) in cm2 increased from 0.74 ± 0.25 at baseline to 1.83 ± 0.46 at discharge and to 1.78 ± 0.45 at 1-year. Mean transvalvular gradient in mmHg was reduced from 38.7 ± 15.2 at baseline to 10.9 ± 4.2 at discharge and to 10.8 ± 5.1 at 1-year. VARC-2 hemodynamic success was achieved in 92% and 95% of patients at discharge and 1-year, respectively. Mild or more PVL was seen in 7.3% and 5.5% and moderate or more PVL was seen in 0.6% and 0.4% of the patients at discharge and 1-year, respectively. Stroke volume index (mL/m2) increased from 35 ± 10 at baseline to 40 ± 11 at discharge and to 41 ± 11 at 1-year (p < 0.001). Conclusions This RESPOND sub-study demonstrates persistently favorable hemodynamic performance and a low rate of PVL in unselected patients through 1-year in the largest Lotus-treated population to date.
Fichier principal
Vignette du fichier
PIIS2474870622003967.pdf (979.92 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04908435 , version 1 (23-01-2025)

Licence

Identifiants

Citer

Osama Soliman, Chun-Chin Chang, Jochen Wohrle, David Hildick-Smith, Sabine Bleiziffer, et al.. A Longitudinal Echocardiographic Analysis of Patients Treated Using the Repositionable and Fully Retrievable Lotus Valve: A Sub-Analysis of the RESPOND Study. Structural Heart, 2020, Structural Heart, 4, pp.26-33. ⟨10.1080/24748706.2019.1686556⟩. ⟨hal-04908435⟩

Collections

UNIV-LILLE
0 Consultations
0 Téléchargements

Altmetric

Partager

More